参考文献/References:
[1] Grazioli L, Federle M P, Brancatelli G,et al. Hepatic adenomas:imaging and pathologic findings. Radiographics,2001, 21(4):877-892.
[2] 许达生,陈君录,黄昭民.临床CT诊断学.广州:广东科技出版社,1998.
[3] Ednaondson HA, Henderson B, Benton B. Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med, 1976, 294(9):470-472.
[4] 正辉,黄志强,董家鸿.亚临床肝癌.北京:军事医学科学出版社,2003.
[5] 彭利,王顺祥,张风瑞.肝细胞腺瘤的诊断和治疗.中华肝胆外科杂志,2002,8(12):721-722.
[6] 金乃善,唐光健.肝细胞腺瘤的CT诊断(附三例报告).中华放射学杂志,1995,29(5):335-337.
[7] Ghaferi AA, Hutchins GM. Progression of liver pathology in patients undergoing the Fontan procedure:Chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg, 2005,129(6):1348-1352.
[8] Chaib E, Gama-Rodrigues J, Ribeiro MA Jr, et al. Hepatic adenoma. Timing for surgery. Hepatogastroenterology, 2007, 54(77):1382-1387.
[9] 叶彩儿,陈伟建,叶民,等.CT检查肝腺瘤误诊4例报告(结合文献17例分析).浙江临床医学,2005,7(6):649-650.
[10] 叶慧义,郭智萍,李俊来,等.肝腺瘤的综合影像诊断.中华放射学杂志,2002,36(2):156-158.
[11] 梁晓辉,杨予川,杨庆艳,等.肝腺瘤的CT诊断与鉴别.黑龙江医学,2007,31(6):415-416.
[12] Bioulac-Sage P, Balabaud C, Wanless IR. Diagnosis of focal nodular hyperplasia:not so easy. Am J Surg Pathol, 2001,25(10):1322-1325.
[13] Grazioli L, Morana G, Kirchin MA, et al, Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumiue-enhanced MR imaging:prospective study. Radiology, 2005, 236(1):166-177.
[14] Corot C, Robert P, Idée JM, et al. Recent advances in iron oxid nanoctystal technology for medical imaging. Adv Drug Deliv Rev, 2006, 58(14):1471-1504.
[15] Daldrup-Link HE, Rydland J, Helbich TH, et al. Quantification of breast tumor mirovascular permeability with femglneose-enhanced MR imaging:initial phase II multicellular trial. Radiology, 2003, 229(3):885-892.
[16] Beets-Tan RG, Van Engelshoven JM, Greve JW. Hepatic adenoma andfocal nodular hyperplasia:MR findings with superparamagnetic iron oxide-enhanced MRI. Clin Imaging, 1998, 22(3):211-215.
[17] Ba-Ssalamah A, Uffmann M, Saini S, et al. Clinical value of MRI liver-specific contrast agents:a tailored examination for a confident non-invasive diagnosis of focal liver lesions. Eur Radiol, 2009, 19(2):342-357.
[18] Stroszezynski C, Gaffke G, Gretschel S, et al. Use of SPIO-enhanced T1-and T2-weighted images for the diferentiation of liver lesions:an ROC analysis. Rofo, 2003, 175(10):1368-1375.
[19] King LJ, Burkill GJC, Scurf ED. MnDPDP enhanced magnetic resonance imaging ofocal liver lesions. Clin Radiol, 2002, 57(12):1047-1057.
[20] Kim MJ, Kim JH, Lira JS, et al. Detection and characterization of focal hepatic lesions:mangafodipir vs. superparamagnetic iron oxide-enhanced magnetie resonance imaging. J Magn Reson Imaging, 2004, 20(4):612-621.
[21] Huppertz A, Haraida S, Kraus A, et al. Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaglng:correlation with histopathologic findings and spiral CT-initial observations. Radiology, 2005, 234(2):468-478.
[22] 刘丽华,祁吉.新型肝脏MRI对比剂对肝细胞腺瘤诊断与鉴别诊断的价值.国外医学放射学杂志,2008,31(2):118-121.
[23] Macarini L, Marini S, Milillo P, et al. Double-corltrast MRI (DC-MRI) in the study of the cirrhotic liver:utility of administering Gd-DTPA as a complement to examinations in which SPIO liver uptake and distribution alterations (SPIO-LUDA) are present and in the identification and characterisation of focal lesions. Radiol Med, 2006, 111(8):1087-1102.
[24] 杨建秀,王从光,于卫中,等.肝腺瘤的超声表现.医学创新研究,2006,3(11):127.
[25] 龙花.B超诊断肝腺瘤10例报告.世界今日医学杂志,2005,6(3):191-192.
[26] Brannigan M, Burns PN, Wilson SR. Blood flow patterns in focal liver lesions at microbubble-enhanced US. Radiographics, 2004, 24(4):921-935.
[27] Kim TK, Jang HJ, Wilson SR. Benign liver masses:imaging with microbubble contrast agents. Ultrasound Q, 2006, 22(1):31-39.
[28] Kim TK, Jang HJ, Burns PN, et al. Focal nodular hyperplasia and hepatic adenoma:differentiation with low-mechanical-index contrast-enhanced sonography. AJR Am J Roentgenol,2008,190(1):58-66.
[29] Dietrich CF, Sehuessler G, Trojan J, et al. Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound. Br J Radiol, 2005, 78(932):704-707.
[30] 卢光明,陈君坤.CT诊断与鉴别诊断.南京:东南大学出版社,1999.
[31] Kume N, Suga K, Nishigauchi K, et al. Characterization of hepatic adenoma with atypical appearance on CT and MRI by radionuelide imaging. Clin Nucl Med, 1997, 22(12):825-831.
[32] Magini G, Farsad M, Frigerio M, et al. C-11 acetate oesnot enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma. Clin Nucl Med, 2009, 34(10):659-665.
相似文献/References:
[1]万绪明,许祖闪,侯红军.磁共振表观弥散系数变化率对肝细胞肝癌患者单次TACE术后疗效评价的应用价值[J].国际放射医学核医学杂志,2015,39(2):129.[doi:10.3760/cma.j.issn.1673-4114.2015.02.006]
Wan Xuming,Xu Zushan,Hou Hongjun.Applieation value of the change ratio of apparent diffusion coefficient in the therapeutic evaluation of hepatocellular carcinoma treated by single transcatheter arterial chemoembolization[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):129.[doi:10.3760/cma.j.issn.1673-4114.2015.02.006]
[2]王振光,王洋洋.PET/CT显像在肝细胞肝癌诊断中的研究进展[J].国际放射医学核医学杂志,2015,39(2):175.[doi:10.3760/cma.j.issn.1673-4114.2015.02.016]
Wang Zhenguang,Wang Yangyang.The development of PET/CT imaging in the diagnosis of hepatocellular carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):175.[doi:10.3760/cma.j.issn.1673-4114.2015.02.016]
[3]黎昕,代海洋,钟华,等.十二指肠Brunner腺腺瘤的CT表现(附7例病例报道)[J].国际放射医学核医学杂志,2015,39(3):239.[doi:10.3760/cma.j.issn.1673-4114.2015.03.011]
Li Xin,Dai Haiyang,Zhong Hua,et al.CT imaging features of duodenal Brunner’s gland adenoma(with 7 cases analysis)[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):239.[doi:10.3760/cma.j.issn.1673-4114.2015.03.011]
[4]张一秋,石洪成.肝细胞癌肿瘤新生血管影像学评价的研究进展[J].国际放射医学核医学杂志,2013,37(1):60.[doi:10.3760/cma.j.issn.1673-4114.2013.01.015]
ZHANG Yi-qiu,SHI Hong-cheng.Advances in assessment of imaging examination for tumor neoangiogenesis induced by hepatocellular carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(2):60.[doi:10.3760/cma.j.issn.1673-4114.2013.01.015]
[5]李红兵,陈勇,曾建国,等.肝动脉化疗性栓塞结合Ⅱ期手术切除治疗巨块型外生型肝癌[J].国际放射医学核医学杂志,2010,34(1):49.[doi:10.3760/cma.j.issn.1673-4114.2010.01.013]
LI Hong-bing,CHEN Yong,ZENG Jian-guo,et al.Treatment of massive extrahepatic growing hepatocellular carcinoma with TACE in combination with secondary resection[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(2):49.[doi:10.3760/cma.j.issn.1673-4114.2010.01.013]
[6]郑磊,李前伟.18F-氟脱氧葡萄糖PET在原发陛肝细胞癌中的应用[J].国际放射医学核医学杂志,2008,32(1):23.
ZHENG Lei,LI Qian-wei.Application of positron emission tomography with 18F-fluorodeoxyglucose in hepatocellular carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(2):23.
[7]周云,刘璐,宋进华.经肝动脉灌注90Y微球治疗肝癌的研究进展[J].国际放射医学核医学杂志,2006,30(6):321.
ZHOU Yun,LIU Lu,SONG Jin-hua.Clinical researched progress of intra-arterial radioembolization with 90Y-glass microspheres for treatment of hepatocellular carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(2):321.
[8]麻广宇,刘家金,徐白萱,等.11C-乙酸盐PET/CT显像在中、高分化肝细胞肝癌复发与转移监测中的应用研究[J].国际放射医学核医学杂志,2018,(4):312.[doi:10.3760/cma.j.issn.1673-4114.2018.04.004]
Ma Guangyu,Liu Jiajin,Xu Baixuan,et al.Application of 11C-acetate PET/CT imaging in the detection of recurrence and metastasis of hepatocellular carcinoma with intermediate and high differentiation[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(2):312.[doi:10.3760/cma.j.issn.1673-4114.2018.04.004]
[9]赵竞,张占文,马慧,等.PET/CT显像剂18F-氟丙酸在肝癌中的生物学评估[J].国际放射医学核医学杂志,2018,(5):414.[doi:10.3760/cma.j.issn.1673-4114.2018.05.005]
Zhao Jing,Zhang Zhanwen,Ma Hui,et al.Biological evaluation of PET/CT imaging agent 18F-fluoropropionic acid in hepatocellular carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(2):414.[doi:10.3760/cma.j.issn.1673-4114.2018.05.005]
[10]陈佩和,徐文贵,李小凤,等.肝细胞肝癌的葡萄糖代谢机制及在PET显像中的应用价值[J].国际放射医学核医学杂志,2018,(6):547.[doi:10.3760/cma.j.issn.1673-4114.2018.06.013]
Chen Peihe,Xu Wengui,Li Xiaofeng,et al.Glycometabolism mechanism in hepatocellular carcinoma and its application in PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(2):547.[doi:10.3760/cma.j.issn.1673-4114.2018.06.013]